Globe Life Inc. (NYSE:GL) Receives $187.40 Average Target Price from Analysts

Globe Life Inc. (NYSE:GL) has received a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $191.6667.

Several equities research analysts have recently commented on the company. Piper Sandler increased their price objective on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Morgan Stanley boosted their target price on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Truist Financial increased their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st.

Insider Activity

In related news, CFO Thomas Peter Kalmbach sold 21,000 shares of the firm’s stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares in the company, valued at approximately $9,105,274.08. This trade represents a 29.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Frank M. Svoboda sold 10,000 shares of Globe Life stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at $9,004,053.60. The trade was a 15.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 169,174 shares of company stock valued at $28,553,849. Company insiders own 2.11% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Compound Planning Inc. grew its position in Globe Life by 4.3% during the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after buying an additional 82 shares during the period. Root Financial Partners LLC raised its position in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after acquiring an additional 83 shares during the period. Transcend Capital Advisors LLC boosted its stake in Globe Life by 3.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after acquiring an additional 84 shares during the last quarter. Natural Investments LLC boosted its stake in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the last quarter. Finally, Parallel Advisors LLC grew its position in shares of Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Stock Performance

GL opened at $182.14 on Wednesday. Globe Life has a 52-week low of $127.85 and a 52-week high of $191.55. The firm has a market capitalization of $14.14 billion, a PE ratio of 12.09 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The business’s 50-day simple moving average is $171.52 and its 200 day simple moving average is $154.26.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period last year, the company posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, sell-side analysts expect that Globe Life will post 15.7 earnings per share for the current fiscal year.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.